Vale SA
VALE
D.R. Horton
DHI
Taylor Morrison Home
TMHC
4
Petroleo Brasileiro SA Petrobras
PBR
5
Ecopetrol
EC
US Stock MarketDetailed Quotes
EDIT Editas Medicine
- 1.315
- -0.095-6.74%
Close Mar 18 16:00 ET
- 1.350
- +0.035+2.66%
Post 20:01 ET
109.11MMarket Cap-0.46P/E (TTM)
1.440High1.310Low1.56MVolume1.410Open1.410Pre Close2.09MTurnover1.88%Turnover RatioLossP/E (Static)82.98MShares7.59552wk High0.81P/B108.65MFloat Cap1.12052wk Low--Dividend TTM82.62MShs Float99.950Historical High--Div YieldTTM9.22%Amplitude1.120Historical Low1.341Avg Price1Lot Size
About Editas Medicine Company
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Company Profile
SymbolEDIT
Company NameEditas Medicine
Listing DateFeb 3, 2016
Issue Price16.00
Founded2013
CEODr. Gilmore O’Neill, M.B.
MarketNASDAQ
Employees246
Fiscal Year Ends12-31
Address11 Hurley Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-401-9000
Company Executives
- Name
- Position
- Salary
- Dr. Gilmore O’Neill, M.B.
- Director, Chief Executive Officer and President
- 2.39M
- Linda Burkly
- Executive Vice President and Chief Scientific Officer
- 1.54M
- Erick J. Lucera, C.F.A.
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 2.22M
- Dr. Jessica Hopfield, PhD
- Chairman of the Board
- 231.07K
- Bernadette M. Connaughton
- Independent Director
- 215.06K
- Andrew J. Hirsch
- Independent Director
- 210.56K
- Dr. Elliott M. Levy, M.D.
- Independent Director
- 264.88K
- Dr. David T. Scadden, M.D.
- Independent Director
- 213.06K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call